a2bp1 polyclonal antibody (Proteintech)
Structured Review

A2bp1 Polyclonal Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 4 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/a2bp1+polyclonal+antibody/A2BP1+Antibody/pmc12099144-73-0-3
Average 93 stars, based on 4 article reviews
Images
1) Product Images from "The Expression Characteristics of the RBFOX1 Gene in Colorectal Cancer"
Article Title: The Expression Characteristics of the RBFOX1 Gene in Colorectal Cancer
Journal: Technology in Cancer Research & Treatment
doi: 10.1177/15330338251333695
Figure Legend Snippet: Copy Number Variation of RBFOX1 and Its Correlation with DFS and OS. A. Online Data from Cbioportal shows that RBFOX1 has the Highest Frequency of Copy Number Deletions in Colorectal Cancer. B And C. Analysis of RBFOX1 Copy Number Situation in Colorectal Adenocarcinoma (TCGA, Firehose Legacy) and Colon Cancer (CPTAC-2 Prospective, Cell 2019) Data. D. KM Survival Curve of Progression-Free Survival and Overall Survival Among the Four Groups.
Techniques Used:
Figure Legend Snippet: Characteristics of RBFOX1 mRNA in Colorectal Cancer. A. Correlation Analysis of Total RBFOX1 Copy Number Variation and RBFOX1 mRNA Expression. B. Differences in RBFOX1 mRNA Expression Among the Four Groups, with Significant Differences Between Groups A And C (**** Represent P < 0.0001), and Significant Differences Between Groups C And D (*** Denotes P < 0.001). C-F. Correlation Analysis of Copy Number Variation and Corresponding mRNA Expression in Each Group Among the Four Groups., C: (Group A–High–Level Copy Number Deletions Group), D(Group B– Represent Low-Level Deletion Group), E(Group C– Normal Group), F(Group D –Copy Number Amplification Group). G. Relative mRNA Expression of RBFOX1 in Colon Adenocarcinoma and Rectal Adenocarcinoma, Indicating that RBFOX1 mRNA Expression in Colorectal Cancer is Lower than in Normal Tissues. H. Correlation between BRAF Gene Mutation and RBFOX1 mRNA in Colon Cancer and Rectal Cancer Tissues. I. Correlation Between PIK3CA Gene Mutation and RBFOX1 mRNA in Colon Cancer and Rectal Cancer Tissues.
Techniques Used: Expressing, Amplification, Mutagenesis
Figure Legend Snippet: Immunofluorescence Analysis of RBFOX1 Protein in Tumor Cells. A. Immunofluorescence from the Human Protein Atlas Database shows that RBFOX1 has Different Nuclear-Cytoplasmic Distribution Characteristics in Cancer Cells of Three Different Tissues. ( https://www.proteinatlas.org/search/RBFOX1 ) B. COSMIC Cancer Cell Engineering shows Copy Number Deletions in Multiple Colorectal Cancer Cells. C. Immunofluorescence shows that RBFOX1 Protein is Mainly Distributed in the Nucleus of Well-Differentiated Tumor Cells HT-29 and SW480, While in Poorly Differentiated HCT116, The Protein shows Nuclear-Cytoplasmic Distribution Characteristics.
Techniques Used: Immunofluorescence
Figure Legend Snippet: Immunohistochemical Analysis of RBFOX1 Expression Level in Normal and Cancerous Colorectal Tissues. A. Immunohistochemical Results from The Human Protein Atlas Database Show that the Protein is Mainly Distributed in the Glandular Cells of the Normal Intestine and shows Low Cytoplasmic Distribution Characteristics, But the Expression of this Protein is not Detected in Colorectal Cancer Tissues, Here are Two Representative Tissues. N1958 Representative an Immunohistochemical Results of RBFOX1 of 84 Years Old Female Patient in Normal Colon Tissue, 1958 is the Patient ID, N1857 Representative an Immunohistochemical Results of RBFOX1 of 47 Years Old Male Patient in Normal Colon Tissue, C4724 Representative an Immunohistochemical Results of RBFOX1 of 70 Years Old Female Patient in Adenocarcinoma Tissue, C4724 Representative an Immunohistochemical Results of RBFOX1 of 82 Years Old Female Patient in Colon Adenocarcinoma Tissue. ( https://www.proteinatlas.org/search/RBFOX1 ). B. Immunohistochemical Results of RBFOX1 in Two High-Throughput Pathological Tissue Chips (Consisting of 69 Colorectal Cancer Tissues). C. A Normal Brain Sample was Used as a Positive Control., On the Left is a 100x Microscopic Image of the Brain, And on the Right is a 200x Magnified Image of a Localized Area on the Left. D. Immunohistochemical Results of RBFOX1 in Intestinal Tissue from a Case of slow Transit Constipation Undergoing Total Colectomy. E. Immunohistochemical Results of RBFOX1 in Three Right-Sided Colorectal Cancers and Adjacent Tissues. N Means Normal, C Means Cancer.
Techniques Used: Immunohistochemical staining, Expressing, High Throughput Screening Assay, Positive Control